Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Paracrine Therapeutics AB
AB
Active
Org 5590252945
Hägervägen 27, 746 34
Bålsta
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2015
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Paracrine Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
-1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 722
445
150
0
195
Staff expenses
—
—
—
—
—
EBITDA
467
−351
−802
−61
172
Depreciation & amort.
−19
−15
−2
−0
−0
EBIT
448
−366
−804
−61
172
Net financials
−7
—
—
—
—
Profit before tax
442
−366
−804
−61
172
Tax
−0
−0
−0
−0
−0
Net profit
442
−366
−804
−61
172
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 049
530
531
890
1 981
Equity
487
121
451
780
1 655
Long-term debt
224
224
9
9
9
Short-term debt
337
185
70
101
316
Total debt
561
409
79
110
325
Financial ratios
5-year trend
EBITDA-margin
88.2%
This company
15.8%
Market median
+458% vs market
2020
2024
Soliditetsgrad
83.5%
This company
38.2%
Market median
+119% vs market
2020
2024
Egenkapitalforrentning
10.4%
This company
18.4%
Market median
+43% vs market
2020
2024
Nettoresultatgrad
88.2%
This company
8.1%
Market median
+989% vs market
2020
2024
Aktivomsætning
0.10×
This company
1.12×
Market median
-91% vs market
2020
2024
Gæld/egenkapital
0.20×
This company
0.62×
Market median
+68% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Paracrine Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
